Nordic Life Science Days 2013: Explore a European Life Science Hotspot

SwedenBIO, in conjunction with its sister organisations in Denmark, Finland and Norway, invites you to attend Nordic Life Science Days 2013.

With focused academic resources and support from both the local investment community and government, the Nordic area is well placed to exhibit itself as a European life science hotspot.  Nordic Life Science Days will showcase this innovation and highlight the best of the region’s pharmaceutical, biotechnology, diagnostic, medtech and digital health industries.

Explore host country Sweden’s thriving life science industry, and learn more from some of the 1000 Swedish life science companies. Learn more about Denmark’s booming biotechnology industry, which employs 40,000, investigate Finland’s flourishing life science industry and discover Norway’s innovative approach to embracing scientific progress, particularly establishing itself as a new player in the oncology field.

“Nordic Life Science Days will showcase the breadth and depth that exists within the Nordic life science sector, and I think the conference programme manages to reflect that dynamics,” says Jonas Ekstrand, acting CEO, SwedenBIO.

Key presentations include:

Early Financing: Soft Money
Dr Björn Kull, Head of the Karolinska Institutet Grants Office, will chair a discussion on financing through the EU framework and Nordic public programmes, which support innovative SMEs and philanthropic funding.

Open Innovation: Collaboration in the Precompetitive Space
Explore the European Commission’s Innovative Medicines Initiative featuring including case studies of successful public and private partnerships   which have discovered new medicines using open access research.

Nanomedicine: The Little Big Revolution
Explore the impact of nanotechnologies in medicine, illustrated by a series of presentations from leading experts in the field.

The European and Nordic Regulatory Landscape
Join the European Medicines Agency and the Committee for Advanced Therapies and investigate current and future regulatory challenges across the board.

Personalized Medicine & BioBanks: Transforming Healthcare by Improving Health Outcomes
Insight on updates on regulatory and business issues, policy, as well as advances in the personalized medicine space.

Special Session on Stockholm Uppsala
Delve into Stockholm’s successful strategic collaborations — industry, academic and research opportunities. Presentations from Karolinska Institutet, Royal Institute of Technology, Stockholm University, Science for Life Lab and the AstraZeneca Translational Science Center will showcase successful business development in Stockholm.